• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ZFEN-P-2-30-124-R
Device Problems Material Separation (1562); Migration (4003)
Patient Problem Rupture (2208)
Event Date 09/12/2020
Event Type  Injury  
Event Description
Patient had z-fen repair in 2016.Follow up ct's showed abdominal aortic aneurysm (aaa) was shrinking per physician and then patient showed up in the er with a ruptured aorta due to proximal and distal body graft overlap coming apart, and the two components were separated.They did not feel they could gain proximal control easily and opened the patient to repair.Proximal z-fen component stayed intact.Physician removed distal stent of proximal component and sewed aorta bifem to proximal.
 
Event Description
Patient had z-fen repair in 2016.Follow up ct's showed abdominal aortic aneurysm (aaa) was shrinking per physician and then patient showed up in the er with a ruptured aorta due to proximal and distal body graft overlap coming apart, and the two components were separated.They did not feel they could gain proximal control easily and opened the patient to repair.Proximal z-fen component stayed intact.Physician removed distal stent of proximal component and sewed aorta bifem to proximal.
 
Manufacturer Narrative
The device was not returned for evaluation.Three unsuccessful requests to obtain additional medical imaging were initiated.The work order was not provided and therefore could not be reviewed against specification.The ifu states that the long-term performance of fenestrated endovascular grafts, including the stents placed in fenestrations/scallops, has not yet been established, and all patients should be advised that endovascular treatment requires life-long, regular follow-up to assess their health and the performance of their endovascular graft.Potential adverse events that may occur and/or require intervention include, but are not limited to: endoleak, component migration.Capa (b)(4) was opened to investigate graft separation.This capa is at the 'capa in progress' stage.Based on the information provided, the root cause of the difficulty reported by the customer is unknown.It is possible that the separation was due to: insufficient fixation (friction) between the proximal and distal components.Inadequate retention forces.Distal device separation.Patient-related factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane QLD 4 113
AS  QLD 4113
MDR Report Key10570667
MDR Text Key208088884
Report Number9680654-2020-00029
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup
Report Date 12/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZFEN-P-2-30-124-R
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/18/2020
Initial Date FDA Received09/22/2020
Supplement Dates Manufacturer Received09/18/2020
Supplement Dates FDA Received12/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-